These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

578 related articles for article (PubMed ID: 17353438)

  • 1. Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study.
    Fox CS; Coady S; Sorlie PD; D'Agostino RB; Pencina MJ; Vasan RS; Meigs JB; Levy D; Savage PJ
    Circulation; 2007 Mar; 115(12):1544-50. PubMed ID: 17353438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
    Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
    Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.
    Peters MJ; van Halm VP; Voskuyl AE; Smulders YM; Boers M; Lems WF; Visser M; Stehouwer CD; Dekker JM; Nijpels G; Heine R; Dijkmans BA; Nurmohamed MT
    Arthritis Rheum; 2009 Nov; 61(11):1571-9. PubMed ID: 19877093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. All-cause mortality risk predictors in a preventive cardiology clinic cohort-examining diabetes and individual metabolic syndrome criteria: a PRECIS database study.
    Doshi KB; Kashyap SR; Brennan DM; Hoar BM; Cho L; Hoogwerf BJ
    Diabetes Obes Metab; 2009 Feb; 11(2):102-8. PubMed ID: 18494803
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for cardiovascular disease in Canada.
    Tanuseputro P; Manuel DG; Leung M; Nguyen K; Johansen H;
    Can J Cardiol; 2003 Oct; 19(11):1249-59. PubMed ID: 14571310
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes.
    Tanasescu M; Leitzmann MF; Rimm EB; Hu FB
    Circulation; 2003 May; 107(19):2435-9. PubMed ID: 12719277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of three different methods of assessing cardiovascular disease risk in New Zealanders with Type 2 diabetes mellitus.
    Metcalf PA; Wells S; Scragg RK; Jackson R
    N Z Med J; 2008 Sep; 121(1281):49-57. PubMed ID: 18797484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The combined impact of blood pressure category and glucose abnormality on the incidence of cardiovascular diseases in a Japanese urban cohort: the Suita Study.
    Kokubo Y; Okamura T; Watanabe M; Higashiyama A; Ono Y; Miyamoto Y; Furukawa Y; Kamide K; Kawanishi K; Okayama A; Yoshimasa Y
    Hypertens Res; 2010 Dec; 33(12):1238-43. PubMed ID: 20927111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance: the Australian Diabetes, Obesity, and Lifestyle Study (AusDiab).
    Barr EL; Zimmet PZ; Welborn TA; Jolley D; Magliano DJ; Dunstan DW; Cameron AJ; Dwyer T; Taylor HR; Tonkin AM; Wong TY; McNeil J; Shaw JE
    Circulation; 2007 Jul; 116(2):151-7. PubMed ID: 17576864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Heart Study.
    Arnlöv J; Evans JC; Meigs JB; Wang TJ; Fox CS; Levy D; Benjamin EJ; D'Agostino RB; Vasan RS
    Circulation; 2005 Aug; 112(7):969-75. PubMed ID: 16087792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five-year incidence of cardiovascular disease and its predictors in Greece: the ATTICA study.
    Panagiotakos DB; Pitsavos C; Chrysohoou C; Skoumas I; Stefanadis C;
    Vasc Med; 2008; 13(2):113-21. PubMed ID: 18593800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.
    Best LG; Zhang Y; Lee ET; Yeh JL; Cowan L; Palmieri V; Roman M; Devereux RB; Fabsitz RR; Tracy RP; Robbins D; Davidson M; Ahmed A; Howard BV
    Circulation; 2005 Aug; 112(9):1289-95. PubMed ID: 16116058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early onset type 2 diabetes mellitus: a harbinger for complications in later years--clinical observation from a secondary care cohort.
    Song SH; Hardisty CA
    QJM; 2009 Nov; 102(11):799-806. PubMed ID: 19734298
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammation biomarkers and near-term death in older men.
    Jenny NS; Yanez ND; Psaty BM; Kuller LH; Hirsch CH; Tracy RP
    Am J Epidemiol; 2007 Mar; 165(6):684-95. PubMed ID: 17215383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community.
    Dhingra R; Sullivan LM; Fox CS; Wang TJ; D'Agostino RB; Gaziano JM; Vasan RS
    Arch Intern Med; 2007 May; 167(9):879-85. PubMed ID: 17502528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality in co-morbidity (II)--excess death rates derived from a follow-up study on 10,025 subjects divided into 4 groups with or without depression and diabetes mellitus.
    Milano AF; Singer RB
    J Insur Med; 2007; 39(3):160-6. PubMed ID: 18251374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Associations of diabetes mellitus with total life expectancy and life expectancy with and without cardiovascular disease.
    Franco OH; Steyerberg EW; Hu FB; Mackenbach J; Nusselder W
    Arch Intern Med; 2007 Jun; 167(11):1145-51. PubMed ID: 17563022
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are traditional risk factors valid for assessing cardiovascular risk in end-stage renal failure patients?
    Shah DS; Polkinghorne KR; Pellicano R; Kerr PG
    Nephrology (Carlton); 2008 Dec; 13(8):667-71. PubMed ID: 18761627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome in Portugal: prevalence and implications for cardiovascular risk--results from the VALSIM Study.
    Fiuza M; Cortez-Dias N; Martins S; Belo A;
    Rev Port Cardiol; 2008 Dec; 27(12):1495-529. PubMed ID: 19280993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.